Peachtree Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Peachtree Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,078	Closed	-$202K	–	91
2015 Q4	$202K	Sell	3,078 -457	-13%	-$28.2K	0.21%	93
2015 Q3	$200K	Hold	3,535	–	–	0.21%	102
2015 Q2	$209K	Hold	3,535	–	–	0.16%	120
2015 Q1	$220K	Hold	3,535	–	–	0.16%	126
2014 Q4	$203K	Hold	3,535	–	–	0.14%	140
2014 Q3	$190K	Buy	+3,535	New	+$187K	0.13%	137
2014 Q2	–	Sell	-4,485	Closed	-$237K	–	139
2014 Q1	$237K	Buy	+4,485	New	+$207K	0.16%	117

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Peachtree Investment Advisors's TEVA Position: Q1 2016 in Review

Peachtree Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 3,078 shares — an estimated $202K sold.

Peachtree Investment Advisors first reported a position in TEVA in Q1 2014 and held it in 7 quarters. The position peaked at $237K in Q1 2014. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Peachtree Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Peachtree Investment Advisors sold 3,078 Teva Pharmaceuticals shares in Q1 2016, an estimated $202K.
Peachtree Investment Advisors first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 7 quarters.
Peachtree Investment Advisors's Teva Pharmaceuticals position peaked at $237K in Q1 2014.
837 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Peachtree Investment Advisors's 13F filing for Q1 2016, filed 11 Apr 2016.